Paloma Partners Management CO United Therapeutics Corp Transaction History

Paloma Partners Management CO

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$170.47 - $211.93 $1.9 Million - $2.36 Million	-11,140 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$153.94 - $174.85 $1.71 Million - $1.95 Million	11,140 New	11,140 $1.86 Million
Q3 2020 Nov 16, 2020	SELL	$99.9 - $121.13 $3.97 Million - $4.81 Million	-39,744 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$92.74 - $125.82 $3.69 Million - $5 Million	39,744 New	39,744 $4.81 Million
Q1 2020 May 15, 2020	SELL	$79.39 - $115.35 $247,538 - $359,661	-3,118 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$78.31 - $95.34 $781,612 - $951,588	-9,981 Reduced 76.2%	3,118 $275,000
Q3 2019 Nov 14, 2019	BUY	$74.85 - $85.99 $980,460 - $1.13 Million	13,099 New	13,099 $1.05 Million
Q2 2019 Aug 14, 2019	SELL	$76.06 - $120.81 $176,002 - $279,554	-2,314 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$107.15 - $126.84 $247,945 - $293,507	2,314 New	2,314 $272,000
Q4 2018 Feb 14, 2019	SELL	$101.4 - $128.73 $224,296 - $284,750	-2,212 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$113.81 - $129.46 $214,873 - $244,420	-1,888 Reduced 46.05%	2,212 $283,000
Q2 2018 Aug 14, 2018	SELL	$101.14 - $118.31 $224,126 - $262,174	-2,216 Reduced 35.09%	4,100 $464,000
Q1 2018 May 15, 2018	SELL	$107.21 - $151.94 $47,601 - $67,461	-444 Reduced 6.57%	6,316 $710,000
Q4 2017 Feb 14, 2018	SELL	$118.58 - $151.28 $779,663 - $994,666	-6,575 Reduced 49.31%	6,760 $1 Million
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $1.53 Million - $1.82 Million	13,335	13,335 $1.56 Million

672

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.